Zenarestat from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
Zenarestat

Description

Zenarestat is an aldose reductase inhibitor. It was investigated as a treatment of diabetic neuropathy and cataract. It was developed by Fujisawa Pharmaceutical Co Ltd and was terminated in clinic phase 3 trials